| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.90M | - | |
| COO | 160.7K | $8.38M | - | |
| CFO | 104.4K | $5.44M | - | |
| Other | 76.0K | $3.96M | - | |
| VP | 29.0K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 | Fairman Jeff | VP, Research | Sale+OE | 131 | $22.50 | $2,947.50 | -2.1% | +14.7% | +98.2% | |
| Nov 19, 2021 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 15,000 | $23.45 | $351,709.90 | -1.3% | -9.2% | +93.9% | |
| Nov 18, 2021 | Guggenhime Andrew46 | President And CFO | Sale+OE | 3,100 | $24.53 | $76,030.50 | -32.8% | -16.6% | +79.5% | |
| Nov 1, 2021 | Sauer Paul | SVP Process Dev, Manufacturing | Sell | 3,000 | $25.00 | $75,000.00 | -8.3% | -23.8% | +80.1% | |
| Oct 26, 2021 | Fairman Jeff | VP, Research | Sale+OE | 4,750 | $22.69 | $107,777.50 | -48.0% | -19.7% | +80.1% | |
| Oct 20, 2021 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 15,000 | $22.58 | $338,755.85 | -1.3% | -18.7% | -0.4% | |
| Sep 27, 2021 | Fairman Jeff | VP, Research | Sale+OE | 4,750 | $26.17 | $124,303.09 | -31.3% | -11.8% | -6.7% | |
| Sep 22, 2021 | Sauer Paul | SVP Process Dev, Manufacturing | Sell | 5,307 | $25.20 | $133,724.19 | -12.8% | -11.5% | -4.1% | |
| Sep 22, 2021 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 15,000 | $25.22 | $378,225.14 | -0.9% | -11.5% | -4.1% | |
| Aug 26, 2021 | Fairman Jeff | VP, Research | Sale+OE | 4,750 | $25.38 | $120,543.00 | -26.0% | -15.4% | +11.2% |